MALIGNANT PRIMARY GLIOMAS
Clinical trials for MALIGNANT PRIMARY GLIOMAS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PRIMARY GLIOMAS trials appear
Sign up with your email to follow new studies for MALIGNANT PRIMARY GLIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on brain tumours shows promise in early trial
Disease control Recruiting nowThis study tests a new drug called paxalisib combined with standard chemotherapy (temozolomide) in people with aggressive brain tumours like glioblastoma. The goal is to see if the combination is safe and can slow tumour growth. About 64 adults will take part, and researchers wil…
Matched conditions: MALIGNANT PRIMARY GLIOMAS
Phase: PHASE1, PHASE2 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated May 17, 2026 00:52 UTC
-
New drug duo takes on deadly brain cancer in early trial
Disease control Recruiting nowThis trial tests two drugs, avutometinib and defactinib, alone or with a third drug (temozolomide), in people with aggressive brain tumors like glioblastoma. The goal is to see if the combination is safe and can shrink tumors or slow their growth. About 182 adults with recurrent …
Matched conditions: MALIGNANT PRIMARY GLIOMAS
Phase: PHASE1, PHASE2 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated May 17, 2026 00:45 UTC